The average one-year price target for Decoy Therapeutics (NasdaqCM:DCOY) has been revised to $30.60 / share. This is an increase of 1,100.00% from the prior estimate of $2.55 dated February 21, 2026.

Decoy Therapeutics ( (DCOY)) has provided an update. Decoy Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on AI-enabled peptide conjugate therapeutics for respiratory viruses ...

DCOY is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of DCOY shares has increased $0.01 since the market last closed. This is a 1.66 ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed.